Keywords

Antidepressive Agents; Depression; Depressive Disorder, Treatment-Resistant; Schizophrenia

Research group(s)

• Clinical Neuroimaging
• Psychosis Imaging Group (Head: M. Willeit)

Selected publications

1. Dold, M. et al., 2017. Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials. Psychotherapy and Psychosomatics, pp.283-291. Available at: http://dx.doi.org/10.1159/000477770.
2. Bartova, L. et al., 2017. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression. The Journal of ECT, 33(3), pp.e31-e32. Available at: http://dx.doi.org/10.1097/YCT.0000000000000421.
3. Bartova, L. et al., 2015. Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases. European Neuropsychopharmacology, 25(11), pp.2183-2184. Available at: http://dx.doi.org/10.1016/j.euroneuro.2015.07.021.
4. Bartova, L. et al., 2015. Reduced default mode network suppression during a working memory task in remitted major depression. Journal of Psychiatric Research, 64, pp.9-18. Available at: http://dx.doi.org/10.1016/j.jpsychires.2015.02.025.
5. Bartova, L., Berger, A. & Pezawas, L., 2010. Is there a personalized medicine for mood disorders? European Archives of Psychiatry and Clinical Neuroscience, 260(S2), pp.121-126. Available at: http://dx.doi.org/10.1007/s00406-010-0152-8.